Did you know?

Bristol-Myers Squibb Co’s stock is NA in 2023, NA in the previous five trading days and down 37.41% in the past year. Currently, Bristol-Myers Squibb Co’s price-earnings ratio is 12.5. Bristol-Myers Squibb Co’s trailing 12-month revenue is $44.9 billion with a 18.4% net profit margin. Year-over-year quarterly sales growth most recently ...The 52 analysts offering price forecasts for Bristol-Myers Squibb have a median target of 70.35, with a high estimate of 95.00 and a low estimate of 50.00. The ...Nov 17, 2023 · Bristol Myers Squibb cut its guidance for the sales of new drugs from $10-$13 bln in 2025 to $10+ bln in 2026. The company now lists 9 medications as part of its new product portfolio. They ... Get the latest Bristol-Myers Squibb Company (BMY) stock price, news, buy or sell recommendation, ... Bristol-Myers Squibb Company News. Actions & Analysis. Nov 30, 2023 7:00 PM EST.Share Price. Bristol-Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. The firm offers chemically ...Forward-looking statements contained on this website should be evaluated together with the many uncertainties that affect Bristol Myers Squibb's business, particularly those identified in the cautionary factors discussion in the company’s most recent annual report on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K.See Bristol-Myers Squibb Company (BMY) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.Healthcare giant Bristol Myers Squibb (BMY-0.20%) is a prime example of Wall Street's sudden renewed interest in these long-forgotten core tenants of stock picking. Image source: Getty Images.The average price target for Bristol-Myers Squibb is $60.69. This is based on 17 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $72.00 ,the lowest forecast is $50.00. The average price target represents 17.80% Increase from the current price of $51.52.Nov 22, 2023 · According to the issued ratings of 18 analysts in the last year, the consensus rating for Bristol-Myers Squibb stock is Hold based on the current 1 sell rating, 13 hold ratings and 4 buy ratings for BMY. The average twelve-month price prediction for Bristol-Myers Squibb is $63.59 with a high price target of $85.00 and a low price target of $50. ... Bristol-Myers Squibb's revenue was $11,406 million in Q4 2022, showing mixed results compared to previous quarters, and there are many explanations for this, which will be discussed in the article ...Nov 24, 2023 · Stock analysis for Bristol-Myers Squibb Co (BMY:New York) including stock price, stock chart, company news, key statistics, fundamentals and company profile. SOPA Images/LightRocket via Getty Images. Bristol Myers Squibb stock (NYSE: BMY) is up 15% in a month, slightly outperforming the broader S&P500 index, up 11%. The rise in BMY stock can be ...A high-level overview of Bristol-Myers Squibb Company (BMY) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Dec 01, 2023, 3:00 am EST. Bristol Myers Squibb stock recently dropped to a multiyear low, and the pharmaceutical company’s lead independent director bought shares on the open market for the ...Get the latest Bristol-Myers Squibb Co (BMY) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and …The company was founded in August 1933 and is headquartered in New Bristol-Myers Squibb Company Common Stock (BMY) S Reconciliations of these non-GAAP financial measures to the most comparable GAAP measures for a particular quarterly period are available on the company’s website at www.bms.com . Discover the stock split history of Bristol Myers Squibb and other stock-related corporate actions taken in the past. Bristol Myers Squibb also plans to continue to explore the potential Bristol-Myers Squibb Company stock price live 49.39, this page displays NYSE BMY stock exchange data. View the BMY premarket stock price ahead of the market session …Get the latest stock price, quote, news and history of Bristol-Myers Squibb Company Common Stock (BMY) on Nasdaq. See real-time data, market cap, label value, bid and … Start your portfolio with Bristol-Myers Squibb ... See the

The 52 analysts offering price forecasts for Bristol-Myers Squibb have a median target of 70.35, with a high estimate of 95.00 and a low estimate of 50.00. The ...Both companies sport stellar A+ credit ratings from S&P. PFE's EBITDA/Interest Expense ratio is a very safe 12.53, while BMY's is even better at 13.59x. On the other hand, PFE has a superior Net ...Find out the direct holders, institutional holders and mutual fund holders for Bristol-Myers Squibb Company (BMY).The pharma giant says that on completion of the acquisition, Celgene is now a wholly owned subsidiary of Bristol-Myers Squibb Company, and that under the terms of the merger, Celgene shareholders received for each share, 1.00 share of Bristol-Myers Squibb common stock, $50.00 in cash without interest, as well as one tradeable …

Summary. Bristol-Myers Squibb Company is facing challenges due to the loss of exclusivity of its drug Revlimid and the need for new product growth. The company made a transformative deal with the ...Bristol-Myers Squibb has increased its dividend for the past 14 consecutive years. When did Bristol-Myers Squibb last increase or decrease its dividend? The most recent change in the company's dividend was an increase of ……

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Jan 31, 2022 · A top big pharma stock. At a hair under . Possible cause: Shares of Bristol Myers Squibb Co. sank 0.24% to $49.98 Monday, on what proved .